Ventas (VTR) director reports 201.433-share acquisition at $69.55

Ventas (VTR): Director Roxanne M. Martino reported an acquisition of 201.433 shares of common stock on 10/16/2025, credited as dividend-equivalent units under the Ventas Non-Employee Directors' Cash Compensation Deferral Plan.

Rhea-AI Filing Summary

Ventas (VTR): Director Roxanne M. Martino reported an acquisition of 201.433 shares of common stock on 10/16/2025, credited as dividend-equivalent units under the Ventas Non-Employee Directors' Cash Compensation Deferral Plan. The grant is payable solely in common stock and reflects the dividend paid on October 16, 2025. The price reference was the $69.55 closing price on the grant date. After this transaction, her beneficial ownership is 62,417.095 shares, held directly.

Insider Trade Summary

Grant/Award: 201.433 shares

Grant/Award 1 txn

Insider Martino Roxanne M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	201.433	$69.55	$14K

Holdings After Transaction: Common Stock — 62,417.095 shares (Direct)

Footnotes (2)

1. F1. Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Cash Compensation Deferral Plan (the "Plan") as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on October 16, 2025. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Plan.
2. F2. Represents the closing price per share of Issuer's common stock as of the grant date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Ventas (VTR) disclose in this Form 4?

Director Roxanne M. Martino reported acquiring 201.433 common shares on 10/16/2025 via dividend-equivalent units.

What was the price reference for the reported Ventas (VTR) shares?

The filing cites the $69.55 closing price per share as of the grant date.

How many Ventas (VTR) shares does the reporting person own after the transaction?

Beneficial ownership is 62,417.095 shares, held directly.

What is the nature of the Ventas (VTR) share acquisition?

Units were granted under the Non-Employee Directors' Cash Compensation Deferral Plan as dividend equivalents, payable solely in common stock.

What was the transaction code on the Ventas (VTR) Form 4?

Transaction code A (grant/acquisition) was reported.

What is the filer’s relationship to Ventas (VTR)?

The reporting person is a Director of Ventas, Inc.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/16/2025 - 06:45 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Martino Roxanne M

(Last) (First) (Middle)

C/O VENTAS, INC.

300 NORTH LASALLE ST., SUITE 1600

(Street)

CHICAGO IL 60654

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Ventas, Inc. [ VTR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/16/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/16/2025		A		201.433(1)	A	$69.55(2)	62,417.095	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Cash Compensation Deferral Plan (the "Plan") as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on October 16, 2025. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Plan.

2. Represents the closing price per share of Issuer's common stock as of the grant date.

Remarks:

	Roxanne M. Martino, By: /s/ Jessica Stricklin, Attorney-In-Fact	10/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.